General updates from the past week:
US COVID-19 cases for January, 2023:
COVID-19 case numbers declined slightly at the end of January after the holiday surge.
As Americans have let down their guard, some gatherings have turned into superspreader events. Included was the Golden Globes where multiple celebrities including Brendan Gleeson, Collin Farrell, Jamie Lee Curtis, Jean Smart and Michelle Pfeiffer reported they will not be attending other awards ceremonies this month because they contracted COVID-19 at the Golden Globes.
A number of celebrities who attended this year's awards test positive for Covid-19 days later.
www.bbc.com
US Deaths from COVID-19 in 2022:
The CDC is estimating that COVID-19 was the 3rd leading cause of death in the US for 2022. However, the overall death rate has declined for 2022 after nearly 1 in 8 deaths in 2021 was caused by COVID-19.
Life expectancy in the United States dropped for the second consecutive year in 2021, falling to the lowest it has been since 1996, according to final mortality data published Thursday by the US Centers for Disease Control and Prevention's National Center for Health Statistics.
www.cnn.com
US Vaccine and Treatment Updates:
There was uncertainty about whether the new bivalent vaccine would offer protection for new variants like XBB.1. The preliminary results of studies estimate that the new bivalent vaccine lowers risk of contracting the new variants by about 50%.
The updated Covid-19 boosters are cutting the risk that a person will get sick from the coronavirus by about half, even against infections caused by the rapidly spreading XBB.1.5 subvariant.
www.cnn.com
However, the news for antibody treatments and new variants is not good. During the alpha and delta variant surge, before vaccines were widely available, antibody treatments were crucial for lowering death rates. However, the new variants have no longer susceptible to existing antibody treatments and the FDA is withdrawing the emergency approvals for these treatments:
Many take Evusheld as an additional layer of protection because the vaccines do not trigger a strong immune response for them.
www.cnbc.com
The FDA is moving toward recommending that the COVID vaccines be administered yearly for most Americans. There is still some discussion underway because COVID-19 is creating variants at a much higher rate than other viruses like influenza.
Also, COVID doesn't have a clear seasonality like influenza; flu seasons are more predictable and the flu shots are can be timed to match the cold/flu seasons in the northern and southern hemisphere. Until the COVID virus in circulation becomes more stable and a clear seasonal pattern is established, we may be getting COVID-19 boosters more often than yearly.
Some say the US Food and Drug Administration’s proposal to update COVID-19 vaccines each year, similar to influenza jabs, could boost uptake.
www.nature.com
COVID-19 in China:
China is still under-reporting both COVID-19 cases and deaths. Since the Chinese government lifted COVID-19 restrictions in late 2022,
an estimated 75% of China's 1.412 billion people have contracted COVID-19.
China has reported 60,000 "official" deaths in hospital from COVID. However, demographers say that the actual number is probably going to exceed 1 million people. COVID-19 has been particularly deadly in rural areas where people tend to be poorer, older and have less access to vaccines and hospitals. Rural areas are reporting a shortage of funeral urms and caskets.
Critically ill COVID-19 cases in China are down 72% from a peak early this month while daily deaths among COVID-19 patients in hospitals have dropped 79% from their peak, the Center for Disease Control and Prevention said on Wednesday.
www.reuters.com
But a second wave could be more deadly
www.economist.com
The BBC finds evidence of a mounting death toll from the virus that's ripped through villages.
www.bbc.com